Results 1 to 10 of about 55,459 (256)

Alternatives to animal testing: A review [PDF]

open access: yesSaudi Pharmaceutical Journal, 2015
The number of animals used in research has increased with the advancement of research and development in medical technology. Every year, millions of experimental animals are used all over the world. The pain, distress and death experienced by the animals during scientific experiments have been a debating issue for a long time. Besides the major concern
Doke SK, Dhawale SC.
exaly   +4 more sources

Antibody-based alternatives to animal testing for toxin detection and antitoxin evaluation [PDF]

open access: yesFrontiers in Toxicology
Animal experiments have long played a central role in biomedical research and toxicology, yet their limitations in translational accuracy and ethical concerns have intensified the demand for reliable alternatives.
Seo-Hyuk Chang   +17 more
doaj   +4 more sources

Alternatives to animal testing to assess MASH drugs and hepatotoxicity. [PDF]

open access: yesHepatology, 2023
The Food and Drug Administration (FDA) Modernization Act 2.0 “allows for alternatives to animal testing for purposes of drug and biological product applications.” This provides an opportunity to develop and improve alternatives to animal studies to assess drugs in the liver.
Brenner DA, Brenner DA.
europepmc   +3 more sources

Towards learning and memory risk assessment with human brain organoids: barriers and opportunities [PDF]

open access: yesFrontiers in Toxicology
Neurodevelopmental conditions, including autism spectrum disorder, intellectual disability, and learning disabilities, as well as neurodegenerative disorders, affect millions of people in the United States alone.
Ronit Mohapatra   +6 more
doaj   +2 more sources

Alternatives to Animal Testing [PDF]

open access: yesJournal of Toxicology: Cutaneous and Ocular Toxicology, 1994
(1996). Alternatives to Animal Testing. Journal of Toxicology: Cutaneous and Ocular Toxicology: Vol. 15, No. 1, pp. 29-31.
  +7 more sources

Using in silico tools to predict flame retardant metabolites for more informative exposomics-based approaches

open access: yesFrontiers in Toxicology, 2023
Introduction: The positive identification of xenobiotics and their metabolites in human biosamples is an integral aspect of exposomics research, yet challenges in compound annotation and identification continue to limit the feasibility of comprehensive ...
Breanne Kincaid   +6 more
doaj   +1 more source

Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues

open access: yesFrontiers in Artificial Intelligence, 2021
Failure to adequately characterize cell lines, and understand the differences between in vitro and in vivo biology, can have serious consequences on the translatability of in vitro scientific studies to human clinical trials.
Vy Tran   +6 more
doaj   +1 more source

Oligodendrogenesis and myelination tracing in a CRISPR/Cas9-engineered brain microphysiological system

open access: yesFrontiers in Cellular Neuroscience, 2023
IntroductionOligodendrocytes (OLs) are the myelin-forming cells of the central nervous system (CNS). Although OLs can be differentiated from human-induced pluripotent stem cells (hiPSCs), the in vitro modeling of axon myelination in human cells remains ...
July Carolina Romero   +6 more
doaj   +1 more source

Weighted Gene Correlation Network Analysis (WGCNA) Reveals Novel Transcription Factors Associated With Bisphenol A Dose-Response

open access: yesFrontiers in Genetics, 2018
Despite Bisphenol-A (BPA) being subject to extensive study, a thorough understanding of molecular mechanism remains elusive. Here we show that using weighted gene correlation network analysis (WGCNA), which takes advantage of a graph theoretical approach
Alexandra Maertens   +5 more
doaj   +1 more source

Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery

open access: yesParticle and Fibre Toxicology, 2019
Background The blood brain barrier (BBB) is the bottleneck of brain-targeted drug development. Due to their physico-chemical properties, nanoparticles (NP) can cross the BBB and accumulate in different areas of the central nervous system (CNS), thus are ...
Paulo Emílio Corrêa Leite   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy